⌘K

Login Start Free

Home/Filings/4/0001562180-25-000453

4//SEC Filing

FRIESON RON 4

Accession 0001562180-25-000453

CIK 0001517022other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 4:06 PM ET

Size

6.8 KB

Accession

0001562180-25-000453

Insider Transaction Report

Form 4

Period: 2025-01-17

Akebia Therapeutics, Inc.AKBA

Director

Transactions

Exercise/Conversion
Common Stock
2025-01-17$0.45/sh+20,100$9,045→ 93,800 total
Exercise/Conversion
Stock Option (Right to buy)
2025-01-17−20,100→ 0 total
Exercise: $0.45From: 2023-06-08Exp: 2032-06-08→ Common Stock (20,100 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1

filerCIK 0001890219

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 4:06 PM ET
Size: 6.8 KB

View on SEC.gov